1. Home
  2. ARTW vs KZIA Comparison

ARTW vs KZIA Comparison

Compare ARTW & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTW
  • KZIA
  • Stock Information
  • Founded
  • ARTW 1956
  • KZIA 1994
  • Country
  • ARTW United States
  • KZIA Australia
  • Employees
  • ARTW N/A
  • KZIA N/A
  • Industry
  • ARTW Industrial Machinery/Components
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARTW Industrials
  • KZIA Health Care
  • Exchange
  • ARTW Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • ARTW 8.6M
  • KZIA 7.8M
  • IPO Year
  • ARTW N/A
  • KZIA 1999
  • Fundamental
  • Price
  • ARTW $1.71
  • KZIA $1.51
  • Analyst Decision
  • ARTW
  • KZIA Strong Buy
  • Analyst Count
  • ARTW 0
  • KZIA 1
  • Target Price
  • ARTW N/A
  • KZIA $20.00
  • AVG Volume (30 Days)
  • ARTW 217.2K
  • KZIA 5.4M
  • Earning Date
  • ARTW 02-26-2025
  • KZIA 03-26-2025
  • Dividend Yield
  • ARTW N/A
  • KZIA N/A
  • EPS Growth
  • ARTW N/A
  • KZIA N/A
  • EPS
  • ARTW N/A
  • KZIA N/A
  • Revenue
  • ARTW $25,181,639.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • ARTW N/A
  • KZIA $806.89
  • Revenue Next Year
  • ARTW N/A
  • KZIA N/A
  • P/E Ratio
  • ARTW N/A
  • KZIA N/A
  • Revenue Growth
  • ARTW N/A
  • KZIA 248000.00
  • 52 Week Low
  • ARTW $1.33
  • KZIA $1.31
  • 52 Week High
  • ARTW $4.15
  • KZIA $15.80
  • Technical
  • Relative Strength Index (RSI)
  • ARTW 46.57
  • KZIA 38.89
  • Support Level
  • ARTW $1.60
  • KZIA $1.31
  • Resistance Level
  • ARTW $1.75
  • KZIA $2.64
  • Average True Range (ATR)
  • ARTW 0.12
  • KZIA 0.23
  • MACD
  • ARTW -0.02
  • KZIA 0.09
  • Stochastic Oscillator
  • ARTW 35.19
  • KZIA 12.78

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: